UltraForce BioSolutions
Biotechnology - Gaithersburg, Maryland, United States
UltraForce BioSolutions Employees
UltraForce BioSolutions Details
Welcome to UltraForce BioSolutionsWith over 200 clinical trials in-play and multiple products approved, the recombinant Adeno-associated viruses (AAV) platform is gaining notoriety, industry focus, and speed. In development, there's a prime directive to optimize upstream and downstream processes for the production of recombinant AAV with consistent quality. To keep pace, AAV Innovators and CDMO's must have the capacity and capability to rapidly characterize critical quality attributes (CQAs) such as virus titer, capsid content, and aggregate content. Opportunities with AUC:Utilizing Analytical Ultracentrifugation (AUC), one can quantify the amount of full genome-containing capsid and the accurate and precise assessment of empty or partially filled capsids. AUC empowers the scientist to reproducibly qualify the number of AAV species and their relative abundances, accurately and precisely, in a single assay. With superior AUC support from UltraForce, there's an opportunity to develop & qualify biophysical characterization assays to support release, characterization, and stability testing of AAV-based gene therapy products. With our support/guidance, your product's status has an opportunity to advance/accelerate! Convert your AAV/AUC Challenges --> Opportunities!As such, a strong arsenal of AAV analytical tools is required that yields actionable results (quickly), bolsters process knowledge/understanding and accelerates development and progress. This requires highly trained AAV-AUC specialists. "Robert Valdes""Keyur Lalani"
UltraForce BioSolutions Technologies
Fonts
Google Font API
Advertising Networks
Linkedin Marketing Solutions
Hosting
Google Cloud Hosting